Other News

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Financial by Comments are Disabled

HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it has been selected for inclusion in the preliminary list of additions to the Russell Microcap® Index, as published by FTSE Russell on Friday, May 23, 2025. The newly reconstituted indexes are expected to take effect after U.S. market close on Friday, June 27, 2025, and be part of the 2025 Russell indexes reconstitution when the U.S. market opens on Monday, June 30, 2025.

Continue Reading →

Kestra Medical Technologies Announces Appointment of Conor Hanley to its Board of Directors

Financial by Comments are Disabled

KIRKLAND, Wash., June 05, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced the appointment of Conor Hanley as an independent director to its board, effective June 4, 2025. “I am delighted to welcome Conor to our board of directors,” said Brian Webster, President and CEO of Kestra Medical Technologies. “He brings deep expertise in medical technology and cardiac care and will serve as an invaluable strategic resource as we grow and expand the reach of the ASSURE® system.” Mr. Hanley is a chartered director and currently serves as CEO of FIRE1, a venture-backed connected medical device solutions company dedicated to improving outcomes for people with heart failure. He previously held senior management roles at ResMed, including leading the cardiology business unit and chronic disease management solutions globally. Prior to ResMed, Mr. Hanley was co-founder and CEO of BiancaMed, a medical device company that was acquired by ResMed. Mr. Hanley earned a PhD in chemical engineering from the University of Pennsylvania and an MBA from INSEAD. His previous board experience includes Enterprise Ireland and chair of APC Ltd. and the Irish MedTech association. “I am honored to join the Kestra board of directors,” said Mr. Hanley. “Kestra is driving much-needed innovation in the wearable cardioverter defibrillator market, and I look forward to collaborating with the management team as the company scales its operations and delivers on its commitments to patients and prescribers.” About KestraKestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com. CONTACT: Investor contact
Neil Bhalodkar
neil.bhalodkar@kestramedical.com

Media contact
Rhiannon Pickus
rhiannon.pickus@kestramedical.com

Continue Reading →

Vensana Capital Welcomes Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner

Financial by 0 comments

MINNEAPOLIS & WASHINGTON–(BUSINESS WIRE)–Vensana Capital, a leading medical technology-focused venture capital and growth equity investment firm, today announced the additions of Maria Berkman, MD, as Partner and Ross (Rusty) Segan, MD, as Venture Partner. Maria Berkman, MD, joins Vensana as a Partner after over a decade at Broadview Ventures, a […]

Continue Reading →

FineHeart Receives ANSM1 Authorization to Deploy Its First-In-Human Clinical Study in France

Coronary/Structural Heart by 0 comments

Patients with advanced heart failure will be treated with FlowMaker®, an innovative, fully implantable device for restoring cardiac output. BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from the French National Agency for the […]

Continue Reading →

TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System

Radiology by 0 comments

DENVER–(BUSINESS WIRE)–TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our investigational immunotherapy, is excited to announce the launch of the TriNav® FLX Infusion System, the latest addition to the […]

Continue Reading →

MemorialCare Heart and Vascular Institute Completes First Successful TriClip Procedure for Tricuspid Valve Repair

Coronary/Structural Heart by Comments are Disabled

LONG BEACH, Calif., June 4, 2025 /PRNewswire/ — The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center’s first transcatheter tricuspid valve replacement…

Continue Reading →

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Regulatory by Comments are Disabled

Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR Systems Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR Systems

Continue Reading →

Vasa Therapeutics Announces Successful Completion of First-in-Human Study for Investigational Therapy VS-041, a Small Molecule Drug Candidate for Heart Failure with Preserved Ejection Fracture

Coronary/Structural Heart by Comments are Disabled

VS-041 safe and well tolerated in healthy patients Biomarker trial in patients with HFpEF targeted to initiate in 2025 ENCINITAS, Calif. and WROCLAW, Poland, June 4, 2025 /PRNewswire/ — Vasa Therapeutics (“Vasa”), a clinical stage biopharmaceutical company developing novel therapies for…

Continue Reading →

MolecuLight to Showcase Innovative Wound Imaging Platform at the Society for Vascular Surgery Vascular Annual Meeting (VAM) 2025

Peripheral/Endo by Comments are Disabled

PITTSBURGH, June 4, 2025 /PRNewswire/ – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM),…

Continue Reading →
1 … 80 81 82 83 84 … 1,298